ReviewInternational journal of molecular sciences2025

Neoadjuvant Immunotherapy in Hormone Receptor-Positive Breast Cancer: From Tumor Microenvironment Reprogramming to Combination Therapy Strategies.

Zimei Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.